Infection after osteosynthesis is an important complication with significant morbidity and even mortality. These infections are often caused by biofilm-producing bacteria. Treatment algorithms dictate an aggressive approach with surgical debridement and antibiotic treatment. The aim of this study is to analyze the effect of such an aggressive standardized treatment regime with implant retention for acute, existing <3 weeks, infection after osteosynthesis.
We conducted a retrospective 2-year cohort in a single, level 1 trauma center on infection occurring within 12 months following any osteosynthesis surgery. The standardized treatment regime consisted of implant retention, thorough surgical debridement, and immediate antibiotic combination therapy with rifampicin. The primary outcome was success. Success was defined as consolidation of the fracture and resolved symptoms of infection. Culture and susceptibility testing were performed to identify bacteria and resistance patterns. Univariate analysis was conducted on patient-related factors in association with primary success and antibiotic resistance.
Forty-nine patients were included for analysis. The primary success rate was 63% and overall success rate 88%. Factors negatively associated with primary success were the following: Gustilo classification (P = 0.023), higher number of debridements needed (P = 0.015), inability of primary closure (P = 0.017), and subsequent application of vacuum therapy (P = 0.030). Adherence to the treatment regime was positively related to primary success (P = 0.034).
The described treatment protocol results in high success rates, comparable with success rates achieved in staged exchange in prosthetic joint infection treatment.
Darouiche RO. Treatment of infections associated with surgical implants. N Eng J Med. 2004;350:1422–9. CrossRef
Parvizi J, Adeli B, Zimistowski B, Restepo C, Greenwald AS. Management of periprosthetic joint infection: current knowledge: AAOS exhibit selection. J Bone Joint Surg. 2012;94:104. CrossRef
Stojicic S, Shen Y, Haapasalo M. Effect of the source of biofilm bacteria, level of biofilm, maturation, and type of disinfecting agent on the susceptibility of biofilm bacteria to antibacterial agents. J Endo. 2013;39(4):473–7. CrossRef
Worlock P, Slack R, Harvey L, Mawhinney R. The prevention of infection in open fractures: an experimental study of the effect of fracture stability. Injury. 1994;25(1):31–38.
Perren SM. Physical and biological aspects of fracture healing with special reference to internal fixation. Clin Orthop Relat Res. 1979;138:175–96.
Saginur R, St. Denis M, Ferris W, Aaron SD, Chan F, Lee C, et al. Multiple combination bactericidal testing of Staphylococcal biofilms from implant-associated infections. Antimircob Agents Chemother. 2006;50(1):55–61. CrossRef
Mihailescu R, Furustrand Tafin U, Betrisey B, Rio L, Maiolo E, Borens O, et al. High efficacy of fosfomycin-rifampin combination against methicillin-resistant Staphylococcus aureus in an experimental model of foreign-body infection. Clin Microbiol Infect. 2012;18:596.
Miller DL, Goswami T. A review of locking compression plate biomechanics and their advantages as internal fixators in fracture healing. Clin Biomech. 2007;22(10):1049–62. CrossRef
Schatzker J. Principles of internal fixation. In: Schatzker J, Tile M, editors. The rationale of operative fracture care. 3rd ed. Berlin: Springer; 2005. p. 3–31. CrossRef
Achermann Y, Eigenmann K, Ledergerber B, Derksen L, Rafeiner P, Clauss M, et al. Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study. Infect. 2013;41:431–7. CrossRef
- Effect of a standardized treatment regime for infection after osteosynthesis
Luke P. H. Leenen
- BioMed Central
Neu im Fachgebiet Orthopädie und Unfallchirurgie
Mail Icon II